EPISODE · Sep 2, 2025 · 1H 15M
從實驗室到華爾街，從 CRO 到全球藥物先鋒｜逸達生技
from MDBros｜Paradigm Shifts in Healthcare · host MDBros
逸達生技以雙軌策略打造穩健成長：一方面透過 SIF 穩定注射平台推出 CAMCEVI®，成功切入美國、歐洲與亞洲市場；另一方面積極開發 MMP-12 抑制劑及 ALDH2 活化劑，挑戰免疫纖維化與罕病領域。公司憑藉全球授權合作、強大的研發與商業化團隊，成功轉型為商業化階段公司。未來關鍵催化劑包括 CPP 三期數據及 NCE Pipeline 的臨床進展，潛力可望帶動台灣生技產業新一波躍升。 -- Hosting provided by SoundOn
Embed this episode
Ready to play
從實驗室到華爾街，從 CRO 到全球藥物先鋒｜逸達生技
0:00
1:15:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MDBros｜Paradigm Shifts in Healthcare?
This episode is 1 hour and 15 minutes long.
When was this MDBros｜Paradigm Shifts in Healthcare episode published?
This episode was published on September 2, 2025.
Can I download this MDBros｜Paradigm Shifts in Healthcare episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!